# Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

> **NCT00064077** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 513 (actual)

## Conditions studied

- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Squamous Cell Carcinoma
- Recurrent Cervical Carcinoma
- Stage IVB Cervical Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Gemcitabine Hydrochloride
- **DRUG:** Paclitaxel
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Topotecan Hydrochloride
- **DRUG:** Vinorelbine Tartrate

## Key facts

- **NCT ID:** NCT00064077
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2011-01
- **Final completion:** 2018-01-30
- **Target enrollment:** 513 (ACTUAL)
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064077, "Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00064077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*